newsfilter
← Latest News
Business Wire·

ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024

ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, today announced that Dr. Dirk Van Hyfte, Head of Innovation at BioStrand, IPA's AI